Extension of Time to File SOU

Trademark

Actelion Pharmaceuticals Ltd.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88064499
LAW OFFICE ASSIGNED LAW OFFICE 104
MARK SECTION
MARK http://uspto.report/TM/88064499/mark.png (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME Actelion Pharmaceuticals Ltd.
MAILING ADDRESS Gewerbestrasse 16
CITY Allschwil
ZIP/POSTAL CODE CH-4123
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Switzerland
PHONE 732-524-2889
FAX 732 524 6341
EMAIL XXXX
OWNER SECTION (proposed)
NAME Actelion Pharmaceuticals Ltd.
MAILING ADDRESS Gewerbestrasse 16
CITY Allschwil
ZIP/POSTAL CODE CH-4123
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Switzerland
PHONE 732-524-2889
FAX 732 524 6341
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Cheryl Foytlin
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TMUS@ITS.JNJ.COM
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) rpetrova@its.jnj.com
CORRESPONDENCE INFORMATION (proposed)
NAME Cheryl Foytlin
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE TMUS@ITS.JNJ.COM
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) rpetrova@its.jnj.com
DOCKET/REFERENCE NUMBER T44052US1
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Human pharmaceuticals for treatment of pulmonary arterial hypertension
GOODS OR SERVICES KEEP ALL LISTED
REQUEST TO DIVIDE YES
EXTENSION SECTION
EXTENSION NUMBER 5
ONGOING EFFORT product or service research or development ; market research
ALLOWANCE MAIL DATE 02/26/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /clfjnj/
SIGNATORY'S NAME Cheryl Foytlin
SIGNATORY'S POSITION Attorney of Record, NY Bar
DATE SIGNED 06/30/2021
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Fri Jul 02 07:42:06 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.XX.XXX-2
0210702074206494053-88064
499-780c9c575a0d65134eeea
d4349dec8788429c661a90e0e
f5ecca85de5ff2aeaf1b4-DA-
42040269-2021063004180217
3808



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: Design only
SERIAL NUMBER: 88064499

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Actelion Pharmaceuticals Ltd., having an address of
      Gewerbestrasse 16
      Allschwil, CH-4123
      Switzerland
      Phone: 732-524-2889
      Fax: 732 524 6341
      Email: XXXX
Proposed: Actelion Pharmaceuticals Ltd., having an address of
      Gewerbestrasse 16
      Allschwil, CH-4123
      Switzerland
      Phone: 732-524-2889
      Fax: 732 524 6341
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 02/26/2019.

For International Class 005:
Current identification: Human pharmaceuticals for treatment of pulmonary arterial hypertension

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


The applicant has submitted a Request to Divide in paper or is filing a Request to Divide as part of the TEAS Allegation of Use form. This is the fifth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development ; market research

Correspondence Information (current):
      Cheryl Foytlin
      PRIMARY EMAIL FOR CORRESPONDENCE: TMUS@ITS.JNJ.COM
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rpetrova@its.jnj.com

Correspondence Information (proposed):
      Cheryl Foytlin
      PRIMARY EMAIL FOR CORRESPONDENCE: TMUS@ITS.JNJ.COM
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): rpetrova@its.jnj.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /clfjnj/      Date Signed: 06/30/2021
Signatory's Name: Cheryl Foytlin
Signatory's Position: Attorney of Record, NY Bar
Signature method: Sent to third party for signature

PAYMENT: 88064499
PAYMENT DATE: 07/02/2021

Serial Number: 88064499
Internet Transmission Date: Fri Jul 02 07:42:06 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.XX.XXX-2021070207420649
4053-88064499-780c9c575a0d65134eeead4349
dec8788429c661a90e0ef5ecca85de5ff2aeaf1b
4-DA-42040269-20210630041802173808



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed